Perbandingan Penggunaan Kontrasepsi Suntik Zat Tunggal dan Kombinasinya terhadap Kejadian Reaksi Obat yang Tidak Dikehendaki di Satu Bidan Praktek Kota Depok

  • Ni Made Ayu Rahmawati Pascasarjana Fakultas Farmasi Universitas Indonesia, Kampus UI Depok, Indonesia
  • Retnosari Andrajati Pascasarjana Fakultas Farmasi Universitas Indonesia, Kampus UI Depok, Indonesia
  • Sudibyo Supardi Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan RI, Indonesia
Keywords: Contraception, DMPA, Estradiol cypionate, ADR

Abstract

Injectable contraceptives raise health problems risk than oral or implan contraceptive. This study aimed to compare the incidence of adverse drug reactions (ADRs) single injectable contraceptive use (Depot medroxyprogesterone acetat/DMPA) with a combination of injectable contraceptive (CICs) use (DMPA and Estradiol cypionate/E2C). The study design was a cross-sectional two population comparison. The sample consisted of 88 acceptors in each group. The ADRs were analyzed using Chi Square and logistic regression multivariate. The largest side effect in single injectable contraceptive group were menstrual disorders (86,4%) and mood dischange, while the side effects in CICs group were mood (64,8%) and bone pain (51,1%). Menstrual disorders in single injectable contraceptives usage was 10.0 folds than CICs. Headache in injectable contraceptives usage was 1.9 folds than in the use of CICs. Menstrual disorders in overweight acceptor 3,8 folds than not overweight.As the ADR observation, the use of CICs is relatively safer than single injectable contraceptive

References

BPS, BKKBN, Kemenkes, ICF International. Indonesia Demographic and Health Survey 2012. Jakarta: 2013.

Kementerian Kesehatan RI. Laporan Hasil Riset Kesehatan Dasar Indonesia Tahun 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan RI; 2013.

Veisi F, Zangeneh M, Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem. Journal of Family and Reproductive Health. 2013 Sep;7(3):109-13.

Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States, J. Contraception. 2007 Oct;76:267–72.

Jain J, Jakimiuk AJ, Bode FR, Ross D, Kaunitz AM. Contraceptive efficacy and safety of DMPA-SC. J.Contraception.

Berenson AB, Odom SD, Breitkopf CR, Rahman M. Physiologic and Psychologic Symptoms Associated with Use the Injectable Contracetive and 20 microg Oral Contraceptive Pills, AM J Obstet

Gynecol. 2008 Oct;199(4):351.e1-351.e12.

Ruminjo JK, Sekadde-Kigondu CB, Karanja JG. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya. J.Contraception. 2005 Aug;72(2):138– 45.

Wulandari P. Perbedaan Peningkatan Berat Badan antara Akseptor Kontrasepsi Suntik Satu Bulanan dengan Tiga Bulanan di Puskesmas II Denpasar Selatan [Skripsi], Denpasar: Universitas Udayana; 2013.

Gholamitabar TM, Moslemi L, Esmaelzadeh S, Bijani A. Comparison of side effects and marital satisfaction between the women taking cyclofem and depot medroxyprogesterone contraceptive

ampoules. African Journal of Pharmacy and Pharmacology. 2012 Jul;6(26):1933-37.

Gallo MF, Grimes DA, Lopez LM, Schulz KF, d’Arcangues C. Combination injectable contraceptives for contraception. The Cochrane Library. 2009;20(3):CD004568.

Biswas P. Pharmacovigilance in Asia. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S7–S19.

Badan POM. Laporan Tahunan Badan Pengawas Obat dan Makanan Tahun 2013. Jakarta, 2014.

Badan Pusat Statistik Kota Depok. Kota Depok dalam Angka 2013/2014. Depok, 2014.

Chandha VK.. Sample Size Determination in Health Studies. NTI Bulletin. 2006, JulDec; 42(3&4): 55-62.

Ozgoli G, Sheikhan Z, Dolatian M, Simbar M, Bakhtyari M, Nasiri M. Comparison of Sexual Dysfunction in Women Using Depo Medroxy progesterone Acetate (DMPA) and Cyclofem. J Reprod Infertil. 2015 AprJun;16(2):102–8.

Anatomy and Physiology. Texas: Rice University;2013.

Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Human Reproduction Update. 2007 Jun,13(5):433–44.

Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006 Jul;113:1148–59.

Wise BL. Niu J, Zhang Y, Felson DT, Bradley LA, Segal N, et al. The association of parity with osteoarthritis and knee replacement in the Multicenter Osteoarthritis Study. Osteoarthritis and

Cartilage. 2013Dec;21(12):1849–54.

Wei S, Schmidt MD, Dwyer T, Norman RJ, Venn AJ. Obesity and Menstrual Irregularity: Associations with SHBG, Testosterone, and Insulin. Obesity. 2009 May;17(5):1070–76.

Najam R, Huda N; Pant A; Chaudhry HH. Assessment of Bone Health in Pregnant Women: A Clinical Study. International Journal of Contemporary Surgery. 2014 Jun; 2(1):64-6

Faiqah S. Perbedaan berat badan dan tekanan darah systole ibu sebelum dan sesudah menggunakan kontrasepsi suntik 3 bulan/depo medroksi progesteron asetat (DMPA) di Puskesmas Gerung Lombok Barat. Media Bina Ilmiah. 2014 Aug;8(5):1-7.

Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA. Effects of the long-term use of depot medroxy progesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. J. Contraception. 2006 Oct; 74(4):297–302.

Hubacher D, Lopez L, Steiner MJ, Dorflinger L.Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception. 2009 Aug;80(2):113–8.

Arias RD, Jain JK, Brucker C, Ross D, Ray A. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception. 2006 Sep; 74(3):234–38.

Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy, A Pathophysiologic Approach. New York: The McGraw-Hill Companies, Inc. 2008:1313-1327.

Simbar M, Tehrani FR, Hashemi Z, Zham H, Fraser IS. A comparative study of Cyclofem® and depot medroxy progesterone acetate (DMPA) effects on endometrial vasculature. J Fam Plann

Reprod Health Care. 2007 Oct;33(4):271-76.

Toffol E, Heikinheimo O, Koponen P, Luoto R, Partonen T. Hormonal contraception and mental health: results of a population-based study, Human Reproduction. 2011 Nov; 26(11):3085-93.

Shepherd JE. Effects of Estrogen on Cognition, Mood, and Degenerative Brain Diseases.J American Pharmacists Association. 2001;41(2):221-8.

Rakhmawati, A. Hubungan obesitas dengan kejadian gangguan siklus menstruasi pada wanita dewasa muda [Artikel Penelitian]. Semarang: Universitas Diponegoro;2012.

Pasquali R, Gambineri A. Symposium: Diet, nutrition and exercise in Reproduction Metabolic effects of obesity on reproduction. Reproductive Bio Medicine Online. 2006 Mar;12(5):542–51.

Norman RJ, Noakes M, Ruijin W, Davies MJ, Moran L, Jim XW, Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update. 2004 May;10(3):267-80.

Published
2017-02-28
How to Cite
1.
Rahmawati NM, Andrajati R, Supardi S. Perbandingan Penggunaan Kontrasepsi Suntik Zat Tunggal dan Kombinasinya terhadap Kejadian Reaksi Obat yang Tidak Dikehendaki di Satu Bidan Praktek Kota Depok. jki [Internet]. 28Feb.2017 [cited 26May2022];7(1):46-4. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/3477
Section
Articles